Newsletter | September 20, 2018

09.20.18 -- Strategic Considerations In Drug Development

Quality By Design: A Holistic Approach To Drug Development
By Anil Kane, Kaspar van den Dries, and Douglas Rufino

As the biopharmaceutical industry continues to evolve, the quality by design (QbD) holistic and proactive approach to drug development and manufacturing is transforming key processes. While QbD evolves from good practice to agency requirement, how can sponsors ensure that rigorous, scientific risk-based approaches are used to bring better and safer therapies to market faster?

Characterizing Drug Substance Properties Early Can Optimize Drug Product Formulation
By Anil Kane

Drug substance characterization is critical to drug product formulation, but characterization and formulation are often not integrated during drug development. This creates needless difficulties, because if drug substance (DS) chemists and drug product (DP) formulators collaborate on a formulation development strategy for early Phase I first in-human clinical studies, they can save time, money, and avoid rework.

How Pacira Pharma Is Working To Help Curb The Opioid Epidemic

Poorly managed postoperative pain often includes the use of opioids for pain relief and can lead to the misuse and abuse of these drugs by patients. The most effective way to stop opioid dependence is to eliminate the use of these addictive drugs after surgery altogether. This was the goal of Pacira Pharmaceuticals.

The Race To Phase III: A Cautionary Tale Of Scalability
By Anil Kane

Production scale-up is rarely straightforward. Scaling up drug product manufacturing often requires time-consuming, expensive, and unexpected challenge resolution. Follow the paths of two companies as they learn how a science-led, risk-based development approach yields a more successful outcome in the long run.

Drug Development: Strategies And Solutions

Whether your company is built on a single molecule or you’re a global pharmaceutical leader, you need fast, cost-effective, and scientifically based insights during early-phase development. Leverage an innovative partner with proven expertise in early development to ensure quick problem solving, speed, and results.